Digoxin for the treatment of chronic and acute heart failure syndromes

Acute Cardiac Care

Volumn 11, Issue 2, 2009, Pages 83-87

  Gheorghiade, Mihai ^a   Harinstein, Matthew E ^a   Filippatos, Gerasimos S ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

digoxin; heart failure; therapy

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; NADOLOL; NEUROHORMONE; PLACEBO; VASODILATOR AGENT; CARDIOTONIC AGENT;

ACUTE HEART FAILURE; CARDIOVASCULAR EFFECT; CHRONIC DISEASE; CLINICAL RESEARCH; CONFERENCE PAPER; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; HUMAN; MONOTHERAPY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SINUS RHYTHM; SYSTOLE; ACUTE DISEASE; DRUG EFFECT; HEART STROKE VOLUME; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

ACUTE DISEASE; CARDIOTONIC AGENTS; DIGOXIN; HEART FAILURE; HUMANS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 70249104303     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940902883246     Document Type: Conference Paper

References (30)

1. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med. 1997;336:525-33.
2. Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-convertingenzyme inhibitors. RADIANCE Study. N Engl J Med. 1993;329:1-7. (Pubitemid 23182871)
3. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993;22:955-62. (Pubitemid 23285742)
4. Ribner HS, Plucinski DA, Hsieh AM, Bresnahan D, Molteni A, Askenazi J, et al. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic-hormonal study. Am J Cardiol. 1985;56:896-904. (Pubitemid 16206962)
5. Arnold SB, Byrd RC, Meister W, Melmon K, Cheitlin MD, Bristow JD, et al. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med. 1980;303:1443-8.
6. Schmidt TA, Allen PD, Colucci WS, Marsh JD, Kjeldsen K. No adaptation to digitalization as evaluated by digitalis receptor (Na,K-ATPase) quantification in explanted hearts from donors without heart disease and from digitalized recipients with end-stage heart failure. Am J Cardiol. 1993;71:110-4. (Pubitemid 23025835)
7. Gheorghiade M, St Clair J, St Clair C, Beller GA. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cardiol. 1987;9:849-57. (Pubitemid 17044931)
8. Gheorghiade M, Hall V, Lakier JB, Goldstein S. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol. 1989;13:134-42. (Pubitemid 19028690)
9. Wang W, Chen JS, Zucker IH. Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation. 1990;81:1959-66. (Pubitemid 20183845)
10. Krum H, Bigger JT, Jr, Goldsmith RL, Packer M. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol. 1995;25: 289-94.
11. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation. 1989;80:65-77. (Pubitemid 19178639)
12. Matsumori A, Ono K, Nishio R, Igata H, Shioi T, Matsui S, et al. Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain. Circulation. 1997;96:1501-6. (Pubitemid 27375343)
13. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Fukai D, Maeda Y, et al. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure. Am Heart J. 1997;134:910-6. (Pubitemid 27522996)
14. van Veldhuisen DJ, Manint Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, et al. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: Results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol. 1993;22:1564-73. (Pubitemid 23336707)
15. Newton GE, Tong JH, Schofield AM, Baines AD, Floras JS, Parker JD. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J Am Coll Cardiol. 1996;28:155-61. (Pubitemid 26266635)
16. Gheorghiade M, Hall VB, Jacobsen G, Alam M, Rosman H, Goldstein S. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors. Circulation. 1995;92:1801-7.
17. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999;99:1788-94. (Pubitemid 29181405)
18. Young JB, Gheorghiade M, Uretsky BF, Patterson JH, Adams KF, Jr. Superiority of 'triple' drug therapy in heart failure: Insights from the PROVED and RADIANCE trials. Prospective randomized study of ventricular function and efficacy of digoxin. Randomized assessment of digoxin and inhibitors of angiotensin-converting enzyme. J Am Coll Cardiol. 1998;32:686-92.
19. Adams KF, Jr, Gheorghiade M, Uretsky BF, Young JB, Ahmed S, Tomasko L, et al. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol. 1997;30:42-8. (Pubitemid 27357125)
20. Jones RC, Francis GS, Lauer MS. Predictors of mortality in patients with heart failure and preserved systolic function in the digitalis investigation group trial. J Am Coll Cardiol. 2004;44:1025-9. (Pubitemid 39165137)
21. Gheorghiade M, van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation. 2006;113:2556-64. (Pubitemid 43948035)
22. Khand AU, Rankin AC, Martin W, Taylor J, Gemmell I, Cleland JG. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol. 2003;42:1944-51. (Pubitemid 37485570)
23. Lynch JJ, Kitzen JM, Hoff PT, Lucchesi BR. Reduction in digitalis-associated postinfarction mortality with nadolol in conscious dogs. Am Heart J. 1988;115:67-76. (Pubitemid 18032702)
24. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med. 2002;347:1403-11. (Pubitemid 35239712)
25. Adams KF, Jr, Patterson JH, Gattis WA, O'Connor CM, Lee CR, Schwartz TA, et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: A retrospective analysis. J Am Coll Cardiol. 2005;46:497-504. (Pubitemid 41040292)
26. Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, et al. Digoxin and reduction in mortality and hospitalization in heart failure: A comprehensive post hoc analysis of the DIG trial. Eur Heart J. 2006;27:178-86. (Pubitemid 43069034)
27. Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: The ancillary digitalis investigation group trial. Circulation. 2006;114:397-403. (Pubitemid 44264821)
28. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557-73.
29. Gheorghiade M, Zannad F, Sopko G, Klein L, Pina IL, Konstam MA, et al. Acute heart failure syndromes: Current state and framework for future research. Circulation. 2005;112:3958-68. (Pubitemid 43739494)
30. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296: 2217-26. (Pubitemid 44708052)